Related references
Note: Only part of the references are listed.Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials
Andrew J. Armstrong et al.
JAMA ONCOLOGY (2020)
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer
Chintan Shah et al.
FRONTIERS IN ONCOLOGY (2020)
Inadequate tissue mineralization promotes cancer cell attachment
Ediz Sariisik et al.
PLOS ONE (2020)
Prostate-specific antigen modulates the osteogenic differentiation of MSCs via the cadherin 11-Akt axis
Longxiang Wu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Molecular mechanisms and clinical management of cancer bone metastasis
Manni Wang et al.
BONE RESEARCH (2020)
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
Eleni Efstathiou et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Ex Vivo Organ Cultures as Models to Study Bone Biology
Teresita Bellido et al.
JBMR PLUS (2020)
Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts
Ali Shokoohmand et al.
BIOMATERIALS (2019)
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Xiangyu Zhang
CANCER COMMUNICATIONS (2019)
Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment
Nathalie Bock et al.
BONE RESEARCH (2019)
Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling
Pradip Shahi Thakuri et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Adipokine RBP4 drives ovarian cancer cell migration
Yanyan Wang et al.
JOURNAL OF OVARIAN RESEARCH (2018)
Mechanisms and Approaches for Overcoming enzalutamide Resistance in Prostate Cancer
Alexandra Vander Ark et al.
FRONTIERS IN ONCOLOGY (2018)
Osteoblastic Factors in Prostate Cancer Bone Metastasis
Song-Chang Lin et al.
CURRENT OSTEOPOROSIS REPORTS (2018)
Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis
Han Qiao et al.
BONE RESEARCH (2018)
Cancer cell motility: lessons from migration in confined spaces
Colin D. Paul et al.
NATURE REVIEWS CANCER (2017)
A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions
Eliza L. S. Fong et al.
BIOMATERIALS (2016)
A systematic review on in vitro 3d bone metastases models. A new horizon to recapitulate the native clinical scenario?
Francesca Salamanna et al.
ONCOTARGET (2016)
Targeting bone metastases in prostate cancer: improving clinical outcome
Jean-Jacques Body et al.
NATURE REVIEWS UROLOGY (2015)
Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review
Marc Bienz et al.
BONEKEY REPORTS (2015)
AR function in promoting metastatic prostate cancer
Michael A. Augello et al.
CANCER AND METASTASIS REVIEWS (2014)
AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis
JuanJuan Yin et al.
CANCER RESEARCH (2014)
PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche
Elana Godebu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Managing bone metastases and reducing skeletal related events in prostate cancer
Benjamin A. Gartrell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids
B. Garcia-Fontana et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide: A Novel Antiandrogen for Patients with Castrate-Resistant Prostate Cancer
Jean Hoffman-Censits et al.
CLINICAL CANCER RESEARCH (2013)
Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer
Pavlos Msaouel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin
Hisanori Uehara et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
The role of engineering approaches in analysing cancer invasion and metastasis
Muhammad H. Zaman
NATURE REVIEWS CANCER (2013)
Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids
Xian Xu et al.
BIOMATERIALS (2012)
Pseudopodial Actin Dynamics Control Epithelial-Mesenchymal Transition in Metastatic Cancer Cells
Jay Shankar et al.
CANCER RESEARCH (2010)
The morphological and molecular features of the epithelial-to-mesenchymal transition
Gema Moreno-Bueno et al.
NATURE PROTOCOLS (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells
Katia Margiotti et al.
MOLECULAR CANCER (2007)
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
Theresa A. Guise et al.
CLINICAL CANCER RESEARCH (2006)
Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival
C. Sun et al.
ONCOGENE (2006)
Elevation of dipeptidylpeptidase IV activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: Possible prostate cancer disease marker
MJ Wilson et al.
JOURNAL OF UROLOGY (2005)
Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: Role of cAMP-dependent protein kinase a signaling pathway
WC Huang et al.
CANCER RESEARCH (2005)
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo
YX Sun et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Osteoblasts in prostate cancer metastasis to bone
CJ Logothetis et al.
NATURE REVIEWS CANCER (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells
N Blaszczyk et al.
CLINICAL CANCER RESEARCH (2004)
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread:: Diagnostic and prognostic implications
K Jung et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Androgens and bone
D Vanderschueren et al.
ENDOCRINE REVIEWS (2004)
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone
Y Lee et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2003)
Share Paper
